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The target gene of miR-185 was predicted by using bioinformatic al-
gorithm. A further luciferase reporter assay was performed to conﬁrm
the speciﬁc binding between miR-185 and the 3’-UTR of its target.
Western-blots assays were used to check relevant gene expression.
RESULTS We found that circulating miR-185 was signiﬁcantly upre-
gulated in CHF patients as well as in the heart tissues from CHF rat
model compared with respective controls. Silencing of miR-185
exhibited a cardiac protective role in doxorubicin induced mice
model. Using Targetscan and Miranda, we identiﬁed AKT1 as the
target of miR-185, which was conﬁrmed by dual luciferase reporter
assays. Ectopic expression of miR-185 enhanced the apoptosis of pri-
mary cardiomyocytes induced by doxorubicin by directly targeting
AKT1. Downregulation of AKT1 phenocopied the pro-apoptotic effect
of miR-185. Furthermore, administration of constitutively active AKT1
promoted primary cardiomyocytes proliferation, and reversed pro-
apoptotic effect of miR-185 overexpression.
CONCLUSIONS MiR-185 exacerbates CHF and reduces cardiomyocyte
proliferation through downregulation of AKT1, suggesting that miR-
185 might be a target to manage cardiac dysfunction.
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OBJECTIVES Atherosclerosis (AS) is the pathological basis of cardio-
vascular and cerebrovascular diseases. The chronic inﬂammation and
lipid inﬁltration theory are thought to be the pathogenesis of AS.
Mononuclear phagocyte (MNP) were key players involved in the lipid
metabolism of plaque and chronic inﬂammation. Pseudolaric acid B
(PB) is an extract of pseudolaricis. Recently, we show that PB could
activate peroxisome proliferator activated receptor g, while is an
important molecular target involved in the process of inﬂammation
reaction and lipid metabolism. Accordingly we hypothesis that PB has
therapeutic potential for AS.
METHODS In vivo study, ApoE-/-mice (8 weeks) were consumed high
fat diet for 8 weeks, then randomly grouped into the baseline group,
high fat diet group, PB treated with high fat diet group, normal diet
group and PB treated with normal diet group (n¼7 each group). We did
experiments as followings, the proportions of monocyte subsets were
analyzed. Confocal microscopy was used to investigate the density of
the proliferation macrophages in plaque of aortic root. Oil Red O
staining was used to explore the plaque size of aortic, common carotid
artery and the aortic root. plasma triglycerides and total cholesterol
concentration were measured by ELISA. In vitro study. Flow cytom-
etry was used to explore the efﬂuence and uptake of lipid in
RAW264.7 cells by Dil-ox-LDL. RAW264.7 cells were intervened with
oxidized low density lipoprotein for 24 hours, which would form foam
cells, then divided into the model group, PB intervention group and
PB with PPARg antagonist block group. The Foam cells were subject to
the following experiments, Oil Red O staining was used to investigate
foam cell. The gene expression of PPARg, LXRa, ABC1 and CD36 was
measured by real-time PCR.
RESULTS In vivo study showed that, the proportion of Ly6Chi
monocyte subsets are lower in PB treated with normal diet（33.01%
3.66% vs. 47.20%3.43%, P<0.05). The density of the proliferation
macrophages are lower in PB treated with normal diet (P<0.05). The
levels of plasma triglycerides and total cholesterol are lower in the
groups of PB treated with normal diet (all P<0.05). The load of plaque
in the root of aorta, common carotid arteries and aorta tended to be
lower in the groups of PB (12.02%1.69% vs. 5.70%1.38%, 7.14%
1.57% vs. 3.71%0.95% and 24.72%3.80% vs. 15.3%1.88%, respec-
tively all P<0.05). In vitro study showed that PB can decrease the level
of lipid in macrophage (P<0.05). PB can increase the gene expression
of PPARg (1.070.36 vs. 3.150.42, P<0.05), LXRa (0.990.06 vs.
2.050.22, P<0.05) and ABC1 (1.880.16 vs.0.960.06, P<0.05).
CONCLUSIONS PB with normal diet not only delay the progression of
atherosclerosis but also reduce plaque burden. PB could activate the
signal pathway of PPARg-LXRa-ABC1 and PPARg-CD36 to regulate the
lipid droplet and efﬂux of foam cells, and inhibit the formation of
foam cells.GW26-e0194
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OBJECTIVES Apelin as a beneﬁcial adipokine has been linked to in-
sulin resistance and cardiovascular protection in diabetes, however,
the underlying molecular mechanisms of how apelin affects myocar-
dial insulin resistance and myocardial injury remain poorly
understood.
METHODS We collected 131 T2DM patients serum, myocardial tissues
of 8 patients with T2DM and 6 accidental deaths without T2DM at
Beijing Hospital. After the TNF-a administration, C57BL/6J male mice
were randomized to receive either vehicle, apelin-13(10mg/kg), or F13A
(a competitive antagonist for apelin receptor 20mg/kg) by i.p.
injection.
RESULTS Plasma samples of 131 patients with type 2 diabetes mellitus
(T2DM) and 54 healthy controls, and myocardial tissues of 8 T2DM
patients and 6 accidental deaths without T2DM were collected.
Increased levels of plasma apelin, ROS and TNF-a were accompanied
by insulin resistance and myocardial injury in patients with T2DM,
similar results were conﬁrmed in diabetic ob/ob mice, suggesting that
apelin, TNF-a and ROS might be correlated with the states of insulin
resistance. In vitro, TNF-a could stimulate myocardial insulin resis-
tance, ROS generation, and apelin expression in H9c2 cells. However,
exposure apelin-13 to TNF-a-treated H9c2 cells and intraperitoneal
injection of apelin-13 to TNF-a-induced insulin-resistant C57BL/6J
mice rescued TNF-a-induced higher intracellular glucose content and
impaired insulin signaling pathway. Moreover, the results demon-
strated that an intraperitoneal injection of apelin-13 improved MI-
induced increased glucose content and cardiac injury as evidenced by
attenuated myocardial infarct size and decreased myocardial
apoptosis in both ob/ob mice and C57BL/6J mice. Further studies
indicated that apelin-13 suppressed ROS generation through down-
regulation of iNOS expression. Finally, F13A, a competitive antagonist
for apelin receptor APJ, suppressed the effects of apelin-13 on insulin
signaling pathway in both insulin-resistant H9c2 cells and insu-
lin-resistant mice. Interestingly, F13A also impaired the effects of
apelin-13 on iNOS expression, demonstrating that apelin ameliorated
TNF-a-induced myocardial insulin resistance by its receptor APJ.
CONCLUSIONS We provide novel experimental evidence that apelin
could ameliorate myocardial insulin resistance and improve myocar-
dial injury though suppressing ROS generation via down-regulation of
iNOS expression, in term, elevating insulin signaling transduction.
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OBJECTIVES Activation of CD4þ T cells plays key roles in facilitating
wound healing after myocardial infarction (MI). However, the mech-
anism of how CD4þ T cells are activated post-MI remains largely un-
known. This study was aimed to clarify whether exosomes derived
from dendritic cells (DCs) mediate activation of CD4þ T cells post-MI.
METHODS Bone marrow-derived DCs (BMDCs) of mouse were incu-
bated with the supernatant of necrotic (Necrosis group) or normal HL-
1 myocardial cells (Control group), or without stimulation (Negative
group). DEXs were then isolated from the BMDCs and identiﬁed by
electron micrograph and Western Blotting using the exosomal marker
proteins. For DEXs tracker and dynamics experiments, the labeled
DEXs (DiR) were injected into mice through tail vein and monitored by
ﬂuorescence imaging. For DEXs uptake experiments, the labeled DEXs
(PKH67) were added to CD4þ T cells suspensions or injected into mice
tail vein, the CD4þ T cells and frozen splenic sections were ﬁxed for
